SCHEMBL4886964

SCHEMBL4886964

[CH2]CSC(C)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL126062 0.72
SCHEMBL22176 0.69
SCHEMBL8937084 0.69
SCHEMBL7994772 0.69
SCHEMBL7028189 0.67
SCHEMBL6469555 0.67
SCHEMBL11135357 0.67 EPHX1 (0.38)
SCHEMBL8171983 0.67
SCHEMBL11239705 0.67
SCHEMBL7055162 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8283005-B2 Inkjet recording medium and method of manufacturing the same FUJIFILM CORPORATION (JP) 2012-10-09 US disclosed
US-20080241438-A1 INKJET RECORDING MEDIUM AND METHOD OF MANUFACTURING THE SAME FUJIFILM CORPORATION (JP) 2008-10-02 US disclosed
US-20080241437-A1 INKJET RECORDING MEDIUM AND METHOD OF MANUFACTURING THE SAME FUJIFILM CORPORATION (JP) 2008-10-02 US disclosed
EP-1459901-A2 Ink-jet recording method Fuji Photo Film Co., Ltd. (JP) 2004-09-22 EP disclosed
EP-0757682-B1 BENZOFURAN DERIVATIVES USEFUL AS INHIBITORS OF BONE RESORPTION FUJISAWA PHARMACEUTICAL CO (JP) 2001-06-20 EP disclosed
US-5858995-A ADMINISTERING TO HUMANS AND ANIMALS IN THE TREATMENT OF DISEASES CAUSED BY ABNORMAL BONE METABOLISM FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-01-12 US disclosed
WO-1995029907-A1 BENZOFURAN DERIVATIVES USEFUL AS INHIBITORS OF BONE RESORPTION FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1995-11-09 WO disclosed